Taliglucerase alfa leads to favorable bone marrow responses in patients with type I Gaucher disease. [electronic resource]
Producer: 20130723Description: 206-11 p. digitalISSN:- 1096-0961
- Adipose Tissue -- metabolism
- Adult
- Aged
- Antibodies -- immunology
- Antibodies, Neutralizing -- immunology
- Bone Marrow -- drug effects
- Enzyme Replacement Therapy -- adverse effects
- Female
- Gaucher Disease -- drug therapy
- Glucosylceramidase -- administration & dosage
- Humans
- Male
- Middle Aged
- Treatment Outcome
- Young Adult
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.